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Introduction: Patients with Turner syndrome demonstrate a variety
of breast deformities that can contribute to their reported lack of self-
esteem, sexual health and social adjustment. Breast reconstruction is
an option for women with TS to correct breast deformities.
Methods: We present three cases of women with Turner syndrome
referred to the Breast Cancer Clinic at Women's College Hospital in
Toronto between 1996 and 2009. Each woman had a breast
deformity despite being on hormone replacement therapy and was
requesting reconstruction to increase their self-esteem, feelings of
femininity and sexual conﬁdence.
Results: Women with Turner syndrome may present with various
breast deformities, including tubular deformities, bilateral devel-
opmental mammary hyperplasia, hypoplasia and asymmetry. Pre-
operative self-ratings of breast appearance ranged from 3 to 6
(1 ¼ hate, 10 ¼ love). All patients reported breast deformities as
having negative effect on self-esteem. All patients received bilat-
eral implant reconstruction resulting in an improved self-rating of
breast appearance.
Conclusions: Women with Turner syndrome and breast de-
formities may beneﬁt from bilateral breast reconstruction.
© 2015 The Authors. Published by Elsevier Ltd on behalf of British
Association of Plastic, Reconstructive and Aesthetic Surgeons. This
is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).al, 76 Grenville St., Toronto, Ontario M5S 1B2, Canada. Tel.: þ1 416 323 7555;
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Turner Syndrome (TS) was ﬁrst described in 1938 by Henry Turner and is now recognized as the
most common sex-chromosome abnormality inwomen. TS affects three percent of females conceived;
however, a 15% spontaneous abortion rate results in a postnatal prevalence of one in 1500e2500 live-
births.1,2
The characteristic TS phenotype includes growth failure with reduced adult height, and gonadal
dysgenesis causing an absence or delay in pubertal development.3 Additional clinical features may
involve cardiovascular, endocrine, renal, gastrointestinal, skin, bone, hearing, and neurological
defects.2,3
The diagnosis of TS requires the presence of the characteristic TS phenotype with complete or
partial absence of the second sex chromosome (the X and/or Y chromosomes), with or without cell line
mosaicism.4 About 50% of TS cases have a genotype of 45,X with a noticeable TS phenotype, 30% have a
45X/46XXmosaicismwith a milder TS phenotype, and about 20% have an incomplete or altered second
X chromosomes causing variable presentations of TS phenotype. These X alterations include ring X,
isochromosome of X (i(Xq) or i(Xp)), and deletions such as the loss of the SHOX (short stature
homeobox-containing) gene which causes short stature.4 Also, a small percentage of TS cases have
some Y chromosome material but are phenotypically female.3
The current treatment guidelines for individuals with TS include recombinant growth hormone
(hGH) therapy to increase height,2 and hormone replacement therapy (HRT) to initiate puberty and
complete growth.4 Important psychosocial factors that have been found to positively impact TS pa-
tients quality of life are age-appropriate pubertal maturation and satisfaction with breast
development.5
However, even with appropriate HRT, some TS patients are dissatisﬁed with their breast develop-
ment.6 This dissatisfaction has been noted in TS patients referred to the Breast Cancer Clinic at
Women's College Hospital (WCH) in Toronto, Ontario for breast reconstruction to correct breast de-
formities associated with inadequate breast development. As part of the medical team of specialists
that provide a continuum of care for women with TS, Plastic surgeons should be familiar with the
appropriate requirements and expertise in treatment of this patient population. The purpose of this
paper is to use three case studies to discuss the etiology and morphology of breast deformities seen in
women with classic or mosaic TS, as well as, the effect breast deformities have on their self-esteem,
sexual health and social adjustment. In addition, this paper will touch on syndrome related co-
morbidities that can affect the ﬁnal cosmetic result, and provide recommendations for optimal
breast reconstruction for these patients.
Cases
Case study #1
The ﬁrst case was a 21 year old woman with Mosaic (45, X,/46X,X) Turner Syndrome who was
diagnosed at age 14. Shewas treated with HRT starting at age 16, and was treated with GH between the
ages of 14 and 16. Her current BMI was 25 and she was a non-smoker. Comorbidities included hypo-
thyroidism, mild aortic stenosis, B12 deﬁciency, inﬂammatory bowel disease, horse-shoe kidney, and
bilateral hearing loss.
She had bilateral developmental mammary hypoplasia, with a bra size of A. She was reconstructed
initially with bilateral submuscular 275 cc saline implants (ﬁlled to 290 cc).
Case study #2
Case study #2 was a 37 year old woman with Mosaic (45,X/46X,X) Turner Syndrome diagnosed at
age 14. She had no history of GH treatment, but a history of HRT treatment from age 14 to 18, and then
from age 34 to current age. Her BMI was 24 and she was a current smoker (half pack per day).
Comorbidities included hypothyroidism, liver dysfunction, osteopenia, and heart murmur. She had
asymmetrical breast development with minor areolar herniation and tubular deformity, with a bra size
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and tubular deformities that can occur inwomenwho do not receive estrogen therapy or fully respond
to their hormone replacement regime during adolescence. She was reconstructed with bilateral sub-
glandular 275 gm gel implants and a right breast Benelli mastoplexy which resulted in a correction of
the tubular deformity and asymmetry.
Case study #3
Case #3Was a 17 yrs old female with Turner Syndrome (45,X). She was diagnosed at age 14 and had
a BMI of 19, small in stature and had completed her growth. She was taking ovarian replacement
therapy (Demulan 30) but had minimal breast development (34 A). The patient presented with a
supportive parent requesting options to obtain a larger breast size. On examination she was 40800, with
symmetrical mammary hypoplasia, small in stature but otherwise proportional (Figure 1). She was
reconstructed with bilateral subpectoral 200 gm gel implants through an inframammary incision
(Figure 2).
Results
The three cases presented women with Turner syndrome who presented with various breast de-
formities, including tubular deformities, bilateral developmental mammary hyperplasia, hypoplasia
and asymmetry. Breast reconstruction was performed on all three cases. None of the patients devel-
oped any keloid formation. Case 1 developed a late hematoma on the right breast three months post-
operatively which required surgery to evacuate the hematoma. She was counseled along with a parent
and consented to a bilateral insertion of a 300 gm round smooth gel implant in the subpectoral plane
through an inframammary incision. No other complications were observed. All three cases had positive
results, with good symmetry and placement.
Womenwere asked to describe the effects of breast appearance on self-esteem. Pre-operative rating
of the breast appearance ranged from 3 to 6 (1 ¼ hate, 10 ¼ love). All three patients reported breast
deformities having a negative impact on self-esteem. Pre-operative qualitative comments regarding
breast appearance included “It doesn't look like a normal breast” (Case 2), and “after estrogen therapy I
didn't notice any breast changes and I didn't feel like a woman” (Case 1).
All patients received bilateral implant reconstruction resulting in an improved self-rating of breast
appearance. Post-operative qualitative comments included “although I have to adjust to the new size, I
would recommend the surgery to other Turner Syndrome patients”.
Discussion
Women with Turner syndrome have to deal with a wide variety of genetic, hormonal and medical
problems. Breast deformities are common in women with TS and can contribute to reported lack of
self-esteem, sexual health and social adjustment. In the current paper which presents two cases of
womenwith Mosaic TS and onewomanwith “classic” TS, we have demonstrated that patient-reported
aesthetic results are improved as a result of breast reconstruction, leading to improvements in self-
esteem.
For women with TS, many of the medical problems that accompany a diagnosis of TS occur during
one of the most difﬁcult transition in human lifedadolescence. For this reason, it is not unexpected
that these women are more vulnerable to psychological problems than their average age group.7e9 In a
study by Sutton et al.,10 97womenwith TS, including 29women between the ages of 7e19, participated
in a qualitative study aimed at understanding the concerns and obstacles TS women experience
throughout their lifespan. The results showed sexual development to be one of the top four primary
concerns throughout each age category, but especially prominent during adolescence.
Delayed or inadequate sexual development is a researched phenomenon in the TS population.
Evidence suggests these women build fewer romantic relationships and experience their sexual debut
later than average women.11 A population-based cohort study of 566 TS women aged 22.6 ± 2.6 yrs
(range 18.3e31.2) correlated incomplete pubertal development with late age of ﬁrst kiss and date of
Figure 1. Case 3 pre-operative images depicting bilateral developmental mammary hypoplasia.
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with limited or absent sexual experiences.12
A contributing factor to their poor psychosexual health is incomplete development of secondary
sexual characteristics, in particular breast development. Although with adequate HRT normal pro-
gression through breast stages has been described, many TS women experience suboptimal breast
development. In an open-randomized multicentre GH dose response study, Bannink et al13 described
the pubertal development of 39 previously untreated TS girls. During the trial, pubertal stage was
determined every 3 months using the criteria and deﬁnitions described by Tanner.14 The results
showed that full breast development occurred in only 50% of the TSwomen compared to 90% of normal
Dutch women, and this development occurred on average 5 years later than the control population.
Figure 2. Case 3 post-operative images depicting reconstruction using bilateral subpectoral gel implants through an inframammary
incision.
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resultant breast deformities.
The advantage of identifying breast development as an impediment to self-esteem, sexual health
and social adjustment of young TS women11,12 is that breasts can be surgically modiﬁed. The cases
presented in this study are examples of how breast reconstruction can positively beneﬁt self-esteem
and sexual conﬁdence. All women reported an improved perception of their breast shape and self-
conﬁdence, and recommended breast reconstruction for other TS women in similar situations. The
challenge, however, is translating this knowledge to the appropriate physicians who can discuss the
option of breast reconstruction andmake a referral to a Plastic surgeon experienced in treating women
with TS.
Although we have demonstrated that breast reconstruction is an acceptable intervention to
improve patient-reported breast aesthetics, there are a variety of comorbidities associated with TS that
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especially relevant in women with monosomy 45, X karyotypes, who have more extreme TS pheno-
types than women with Mosaic TS. It should also be recognized that women with TS are reported to
frequently become obese as they age,15 which may exacerbate the underlying breast deformity and
result in necessary revisions to improve the breast shape and contour. Furthermore, although not
demonstrated in these case studies, TS women are prone to developing keloids1,4,16 and if applicable
careful consideration of incision sites and follow-up care would be required.
Patients with TS demonstrate a variety of breast deformities that can contribute to their reported
lack of self-esteem, sexual health and social adjustment. As such, plastic surgeons can be important
team members involved in the care of TS patients throughout their lifespan. The option for breast
reconstruction, however, needs to be discussed with appropriate TS patients by their most responsible
physician. Once this option becomes increasingly available, more research can be done to fully un-
derstand the surgical challenges unique to this population and provide better guidelines for optimal
breast reconstruction.
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